Leumas Secures $2.2 Million Seed Funding for Deeptech Manufacturing Expansion

Leumas, a deeptech manufacturing startup, has successfully raised $2.2 million in a seed funding round led by Capital 2B, a fund specialising in deeptech, which is supported by Info Edge and Temasek. The investment also saw participation from Capital-A and Anicut Capital.

The funding will enable Leumas to enhance its research and development capabilities, bolster its on-demand manufacturing infrastructure, and initiate pilot projects for dedicated factories tailored for wellness and pharmaceutical brands, as stated in a recent press release.

About Leumas and Its Innovative Solutions

Founded in 2016 by Subhajit Biswas and Nitesh K, Leumas offers cutting-edge on-demand manufacturing and factory-as-a-service solutions specifically designed for wellness and pharmaceutical sectors. Their offerings are based on software-defined, modular robotic factories that significantly enhance both manufacturing and business outcomes, encompassing everything from development to large-scale production.

Leumas combines automation, software intelligence, and research and development to assist brands in scaling efficiently, ensuring quality, and minimising risks.

Core Product and Technological Advancements

The startup’s flagship product revolves around cyber-physical manufacturing technology, characterised by software-driven, modular production lines that incorporate AI-led robotics, vision-based quality systems, and autonomous operations. This innovative technology guarantees optimal production output while adhering to regulatory requirements.

Market Potential for Outsourced Manufacturing

According to industry research, the market for outsourced development and manufacturing within the pharmaceutical and wellness sectors is projected to surpass $400 billion by 2030.

Recent Achievements of Leumas

Over the last year, Leumas has collaborated with leading wellness brands to develop its manufacturing solutions, successfully scaling more than 120 products across India, the United States, and the MENA region. Additionally, the startup has entered into agreements with notable pharmaceutical and food research institutions to establish dedicated factory capacities using its modular factory technology.